Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 6, 2019
Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibioticAlain Scaiola, Marc Leibundgut, Daniel Boehringer, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infectionsHans H Locher, Patrick Caspers, Thierry Bruyère, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2020
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwideHelio S Sader, Paul R Rhomberg, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Peptide deformylase as an antibacterial drug target: target validation and resistance developmentC M Apfel, H Locher, S Evers, et al.
Frontiers in Microbiology|August 15, 2020
Identification of Genes Required for Resistance to Peptidomimetic Antibiotics by Transposon SequencingAlessandra Vitale, Gabriella Pessi, Matthias Urfer, et al.
Chemotherapy|August 18, 2010
Dimers of nostocarboline with potent antibacterial activityHans H Locher, Daniel Ritz, Philippe Pfaff, et al.
Frontiers in Neurology|November 8, 2024
The evolution of intractable Ménière's disease: attacks resolve over timeF R Gerritsen, A A Schenck, H Locher, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of actionChristian Hubschwerlen, Jean-Luc Specklin, Daniel K Baeschlin, et al.
Histochemistry and Cell Biology|March 1, 2015
Hair follicle bulge cultures yield class III β-tubulin-positive melanoglial cellsH Locher, N Saadah, S de Groot, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitorsC Apfel, D W Banner, D Bur, et al.
Pageof 5